+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Use of a physiologically based pharmacokinetic pb pk nicotine cotinine model to assess the influence of nicotine on the distribution of cotinine in man



Use of a physiologically based pharmacokinetic pb pk nicotine cotinine model to assess the influence of nicotine on the distribution of cotinine in man



FASEB Journal 5(6): A1568




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034147734

Download citation: RISBibTeXText


Related references

A physiologically based pharmacokinetic model for nicotine and cotinine in man. Journal Of Pharmacokinetics & Biopharmaceutics. 20(6): 591-609, 1992

Population pharmacokinetic model for nicotine (NIC) metabolism to cotinine (COT) and 3-hydroxy cotinine (3HC) in healthy volunteers. Clinical Pharmacology & Therapeutics 73(2): P21-P21, 2003

Population pharmacokinetic model for nicotine metabolism to cotinine and 3-hydroxy cotinine in healthy volunteers. Clinical Pharmacology & Therapeutics 73(2): P21, 2003

Constant-rate infusion of nicotine and cotinine. I. A physiological pharmacokinetic analysis of the cotinine disposition, and effects on clearance and distribution in the rat. Journal of Pharmacokinetics and Biopharmaceutics 15(6): 583-599, 1987

High performance liquid chromatographic determination of nicotine and cotinine in plasma and nicotine and cotinine, simultaneously, in urine. Methods and Findings in Experimental and Clinical Pharmacology 11(3): 179-185, 1989

Human blood concentrations of cotinine, a biomonitoring marker for tobacco smoke, extrapolated from nicotine metabolism in rats and humans and physiologically based pharmacokinetic modeling. International Journal of Environmental Research and Public Health 7(9): 3406-3421, 2011

Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model application. Journal of Pharmacokinetics and Pharmacodynamics 34(1): 23-34, 2007

Simultaneous GC-MS determination of nicotine and cotinine in plasma for the pharmacokinetic characterization of nicotine in rats. Journal of Pharmaceutical & Biomedical Analysis 20(1-2): 195-202, 1999

Simultaneous GC-MS determination of nicotine and cotinine in plasma for the pharmacokinetic characterization of nicotine in rats. Journal of Pharmaceutical and Biomedical Analysis 20(1-2): 195-202, 2000

Binding of cotinine and nicotine to rat liver cytochrome p 450 comparison with metyrapone and effects of monoclonal anti cotinine and anti nicotine antibodies. FASEB Journal 4(7): A1891, 1990

Pharmacokinetic analyses of nicotine and cotinine levels in the HAS/CAS/LAS rats which have been shown to be differentially sensitive to nicotine. Alcoholism Clinical & Experimental Research 22(3 ABSTR SUPPL ): 100A, 1998

The contribution of dietary nicotine and dietary cotinine to salivary cotinine levels as a nicotine biomarker. Food chemistry 74(3): 259-265, 2001

Active immunization against nicotine alters the distribution of nicotine but not the metabolism to cotinine in the rat. Naunyn-Schmiedeberg's Archives of Pharmacology 370(4): 299-304, 2004

Postmortem distribution of nicotine and cotinine from a case involving the simultaneous administration of multiple nicotine transdermal systems. Journal of Analytical Toxicology 21(4): 310-313, 1997

The analysis of nicotine-1'-N-oxide in urine, in the presence of nicotine and cotinine, and its application to the study of in vivo nicotine metabolism in man. Journal of Pharmacy and Pharmacology 23: 55s-61s, 1971